Shinyoung Wacoal

Shinyoung Wacoal began as Shinyoung Textile Dyeing Company in 1954, incorporated in 1968, and adopted its current name in 1994 when Japan's Wacoal took an equity stake, becoming Korea's leading women's foundation and lingerie specialist.

The company operates multiple foundation and lingerie brands including Venus, Wacoal, Solb, Motherpia, Orhwa, Salute, Remamma, Aneta, and Arbo, with Remamma—a dedicated underwear brand for women who have undergone breast cancer surgery—being the only such category offering in the domestic market.

As a women's underwear specialist, the company holds a 54.1% market share within department-store sales, preserving a dominant position in the traditional retail channel.

Control rests with the founding family, with Chairman Lee Eui-pyeong and his son, CEO Lee Sung-won, among related parties holding stakes under a co-CEO structure, while Japan's Wacoal Holdings remains the second-largest shareholder with a 25% stake acquired through a 1994 rights offering.

More recently, the company has focused on customized product development using CRM systems and 3D body scanners, while pursuing channel expansion into online and live-commerce platforms to bolster competitiveness.

On the competitive front, traditional innerwear makers such as BYC and Ssangbangwool's Vivien are expanding seamless and wireless bra lines, while fashion companies like Shinsegae International have also entered the comfort-focused innerwear segment, intensifying competition.

Notably, majority shareholder Japan Wacoal Holdings has separately announced plans to enter the automotive interior materials market using its 3D-molding textile technology, though this is a strategic move by a distinct corporate entity and does not directly alter Shinyoung Wacoal's own domestic business structure.

Given its domestically focused business, the company remains sensitive to consumer sentiment and the broader economy, though underwear's status as a near-essential good supports baseline demand, and growing health and wellness interest is cited as a relative tailwind for premium and functional product lines.

Annual revenue rose slightly from KRW 201.4 billion in 2022 to KRW 202.8 billion in 2023, before declining for two consecutive years to KRW 196.7 billion in 2024 and KRW 185.2 billion in 2025, a roughly 8% drop over four years.

Operating margin fluctuated from 3.3% in 2022 to 1.1% in 2023, 1.4% in 2024, and 0.7% in 2025, showing an overall thinning trend.

In 2025, revenue fell 5.9% year-on-year to KRW 185.15 billion from KRW 196.68 billion, and operating profit plunged 53.2% to KRW 1.29 billion from KRW 2.76 billion, which the company attributed to lower revenue and rising raw material costs.

In contrast, 2025 net income attributable to owners rose 60.8% year-on-year to KRW 6.27 billion from KRW 3.90 billion, which the company said reflected temporary non-operating gains from subsidiaries and affiliates.

Looking at the quarterly pattern, the company posted revenue of KRW 57.89 billion with an operating loss of KRW 0.13 billion in 2Q 2025, then swung to an operating profit of KRW 2.78 billion on revenue of KRW 47.54 billion in 3Q 2025, before revenue collapsed to KRW 33.52 billion in 4Q 2025 alongside a sizable operating loss of KRW 3.34 billion and a net loss of KRW 3.40 billion.

In 2026, the company returned to small-scale profitability with revenue of KRW 44.20 billion and operating and net profit of KRW 0.18 billion each in 1Q, while 2Q revenue climbed to KRW 59.37 billion even as operating profit slipped to a small loss of KRW 0.045 billion, with net income of KRW 0.21 billion.

As a result, net income attributable to owners over the most recent four quarters (3Q 2025 through 2Q 2026) totaled roughly KRW 1.63 billion, well below full-year 2025 net income of KRW 6.27 billion, underscoring how the large 4Q 2025 loss weighed on the recent earnings trend.

Overall, core operating profitability has structurally thinned in recent years, while net income defense has increasingly relied on factors outside the core business.

According to a survey by the Korea Fashion Industry Association, the domestic underwear market has been estimated at roughly KRW 2 trillion, a mature market with limited growth competed for by numerous players.

The global lingerie market was estimated at USD 66 billion in 2025 and is projected to grow at a 5.7% compound annual rate between 2026 and 2035, suggesting relatively more growth headroom overseas than domestically.

The ongoing shift in consumer purchasing channels from department stores and franchise outlets toward online and home-shopping platforms remains a persistent challenge for Shinyoung Wacoal, which has traditionally held a strong position in department-store channels.

Competitors are responding with comfort-focused seamless and wireless bralette products, with BYC and Ssangbangwool's Vivien expanding related lines and fashion companies such as Shinsegae International also entering the market with growing bralette sales.

This rise in new entrants adds to the burden of defending market share for traditional underwear specialists. Raw material price volatility directly affects the cost structure across the industry, and Shinyoung Wacoal itself cited rising raw material costs as a key driver behind its weaker 2025 operating performance.

Given its heavy reliance on large offline retail networks such as department stores and franchise agencies, the business remains sensitive to macro factors like offline foot traffic trends and consumer sentiment.

The company attributed its weak 2025 performance to declining revenue and rising raw material costs, suggesting cost management will remain a key challenge into 2026. Both 1Q and 2Q 2026 operating profit hovered near breakeven, pointing more toward a gradual stabilization phase than a clear margin recovery signal.

According to corporate information providers such as FnGuide, the company is responding through CRM- and 3D body scanner-based customized products along with expansion into online and live-commerce channels, and the actual revenue contribution of this channel diversification will likely be a key point to monitor going forward.

Given that the fourth quarter has proven seasonally weak (with an operating and net loss in 4Q 2025), whether 4Q 2026 repeats a similar pattern is a central item to watch.

No specific mid- to long-term capacity expansion, major investment, or overseas expansion plans have been disclosed; the company appears focused on maintaining its existing brand portfolio and distribution network while pursuing gradual channel transition.

On the net income side, the presence or absence of one-time gains from subsidiaries and affiliates is likely to continue driving quarter-to-quarter volatility, making it important going forward to distinguish core operating profit from net income that includes non-recurring items.